LRRK2 and Parkinson disease: Our results indicate PUMs regulate the expression of the clinically relevant PD genes SNCA and LRRK2, and that cellular alteration in PUM levels leads to increased mRNA expression of these PD-associated genes and a significant increase in the abundance of the α-syn protein.